miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. - Wikidata - awgldk - TriplyDB

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.

http://www.wikidata.org/entity/Q34311399

about

Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans Novel RNA markers in prostate cancer: functional considerations and clinical translation Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls.Epigenetic alteration and microRNA dysregulation in cancer MicroRNA Methylation in Colorectal Cancer.Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via up-regulation of RARβ2 and RASSF1A demethylation Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters.Differentially expressed wound healing-related microRNAs in the human diabetic cornea.Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression.Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma MicroRNAs and epithelial-mesenchymal transition in prostate cancer.The role of miR-24 as a race related genetic factor in prostate cancer.Roles of microRNAs during prostatic tumorigenesis and tumor progression.The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer.MicroRNAs and drug resistance in prostate cancers.The p53/miR-34 axis in development and disease.Epigenetic modifications in prostate cancer.miRNA and methylation: a multifaceted liaison.Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.Missing link between microRNA and prostate cancer.RB Loss Promotes Prostate Cancer Metastasis.MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches.Understanding the CREB1-miRNA feedback loop in human malignancies.Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies.Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.Deciphering the function of non-coding RNAs in prostate cancer.Genome-wide association studies and epigenome-wide association studies go together in cancer control.Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.Investigational serine/threonine kinase inhibitors against prostate cancer metastases.Epigenetic dysfunctional diseases and therapy for infection and inflammation.MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.Methylation and microRNA-mediated epigenetic regulation of SOCS3.miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI.

P2860

Q26739708-A6EA375B-0648-462B-8D80-A1CEBD869EEC Q27008271-F2757909-B0A2-43B6-9AA4-6F2724F7AA20 Q27021174-D0993DF2-D0EF-41F9-AED8-4C4B4DD13549 Q28257722-B11BA411-A218-4A14-B8C3-F1AEAEF27C18 Q33827330-36CA969B-0899-4BF6-B239-EBBF15A885B9 Q34392645-070729AB-5665-4BF4-A9A4-3D49E5EA0940 Q34538870-5283F2EC-940A-4DC3-8693-CE60D9FD82D4 Q34835780-38190642-B3CC-4EAF-97C5-763E1D7361DF Q34956940-3BE75FCF-ED6E-43F9-A8B5-6DBAD4B3971C Q35078390-9DF74F9B-4559-4FA2-B859-3556BD4B7CB0 Q35104159-DCFE1C52-F46D-4298-A5A3-9EDDE42E4066 Q35672901-5E045A77-322B-40EF-B9EF-6F6E4302A8C2 Q36376636-6D85EF5C-14DC-4D3E-8394-A8C24EEA878B Q37687205-44A205D6-B1C6-4A34-A8A7-0A56BEDAA7A3 Q37725482-0CE5045D-E044-47B9-AE15-B511789BF4E1 Q38086009-72905837-6881-4F81-922F-247EA7083F21 Q38160734-D6EFA606-4FAF-4C87-83C3-C32CC8EB2E08 Q38205266-5BB13E4A-FD51-40A5-AA25-0DF7F7277433 Q38210767-6E3708A9-5CC9-497D-945B-FB843C08A60C Q38261747-3B746D31-FF21-4496-8F94-271E60C76241 Q38282163-885EB3C1-44A5-445C-B6D7-0E7C6392C716 Q38667234-8EA70BA2-1F76-4A0E-8ADB-5DB0551B85D7 Q38715316-8BF68B87-0218-43C4-9C6F-9BEB72692382 Q38727367-7ACBC27E-0F11-42AB-823A-A6CCA8EA139A Q38740509-AE3CA4D9-CA3E-4516-8786-677E826C50ED Q38771880-54649F74-CF7C-4C41-9220-D3CA50A8AF67 Q38802458-2F02AB53-0B4F-45D6-9DB3-1B9DC3251C6E Q38811147-39DF63F9-C20B-49DE-9836-B5A1FFB29878 Q38816103-8CD7C96D-EDFB-44AF-A255-94BBD9568765 Q38843392-95BF6A1D-B02F-4314-A349-E54D5EC11A77 Q38881089-121BA04E-3803-4CBB-A1D5-457CE7A5CA7F Q38885469-CC380F26-09BC-4376-A983-B68873C6EAB2 Q38937332-C5A5F2C5-CF08-48AB-A993-F82C2DFD8090 Q39021945-0CF6C839-BEE8-43B3-B711-E7C951CC3DA7 Q39029869-794C4EBA-36E1-4E8D-8C7B-C749CA1BEE5E Q39037653-FF708E9D-DFC5-4A74-9C5A-B19BDD6CA8CE Q39137248-85412AA9-ACA1-48EA-896A-55E9D17DF13C Q39369349-06B4776A-74A5-43D7-AA5E-A4B93B5A938A Q41240274-5C1BD674-B831-4569-9FEC-F120271002E0 Q42965204-698B2D58-9EBE-4EEF-82A5-7CF4290F6A40

P2860

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.

http://www.wikidata.org/entity/Q34311399

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@ast

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@en

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@nl

type

label

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@ast

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@en

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@nl

prefLabel

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@ast

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@en

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@nl

P1433

Q34311399-AD664168-F01E-4E5E-AA84-BC3A227FF1CA

P1476

Q34311399-0A2445F3-DD8C-4744-AF0E-F04FB3952531

P2093

Q34311399-002AA92D-F226-466F-9A5C-058F8E38D365

Q34311399-056E476A-20EF-43B9-9433-70F60272F46A

Q34311399-3EFAFC1A-F5E4-4A34-A5E6-5171A60B7B16

Q34311399-4436D203-AA56-4C19-8AA8-B6D1CAAF181C

Q34311399-5A85FA98-F447-4752-9A6F-4250FA3A58C9

Q34311399-64603369-3FF2-4769-8A2C-831D3D950359

Q34311399-73A34319-CE66-44DE-A571-0A8CDB8F29BB

Q34311399-A2783EDC-A552-4446-BECB-EBE30100713B

Q34311399-A59E80AE-FC45-41F4-95F0-C989301C7993

Q34311399-A941FE8F-1883-40A4-8C87-DA2CDA1C0861

P2860

Q34311399-0F150D90-C2A6-4FD5-B228-F5EADB222BAC

Q34311399-1397F5E5-7806-464D-89E8-32BF815C9BC5

Q34311399-143ADDF6-880A-49DF-920F-5870E160860B

Q34311399-1ED724E5-D80F-40BF-8D7B-8A2DB67D18A3

Q34311399-1FE4F87F-875A-434E-AB37-044AD100E9A1

Q34311399-20B29811-0362-45B8-8B18-2667C3AA2C35

Q34311399-2607E32F-2558-4A90-9692-E0CE377BD4B0

Q34311399-2670EA90-EC46-4FDD-94EA-0A26D9EDD358

Q34311399-27642E8D-99AF-4C23-82B8-90C9C61EFD9E

Q34311399-2B0F724F-45A0-43EE-8B24-664B4C323637

P304

Q34311399-54F206B1-11EA-4835-8054-A1B28228CFB3

P31

Q34311399-507EFE58-F80F-4C78-A5AD-2831A782E47C

P356

Q34311399-4CC153A1-E0ED-435D-ABBF-4DF6FEB9E8AC

P407

Q34311399-DADBB5D0-BA67-47C7-84E9-376B3FA958D5

P433

Q34311399-3A055DE0-DB8B-4EF3-8535-163EC9177E9F

P478

Q34311399-21E07F78-75C9-4F13-A94B-074BAF0F16AD

P577

Q34311399-608230EA-090E-4BDE-803C-BFCD7A3247E7

P698

Q34311399-DD0697A1-2DB9-4596-A725-84FD70522AAF

P932

Q34311399-905FE104-07E4-4921-A2B5-2A2FB3AFDE7D

P356

1078-0432.CCR-12-2952

P1433

Clinical Cancer Research

P1476

miRNA-34b inhibits prostate ca ...... difications, and AKT pathways.

@en

P2093

Altaf A Dar

http://www.w3.org/2001/XMLSchema#string

Guoren Deng

http://www.w3.org/2001/XMLSchema#string

Inik Chang

http://www.w3.org/2001/XMLSchema#string

Mohd Saif Zaman

http://www.w3.org/2001/XMLSchema#string

Rajvir Dahiya

http://www.w3.org/2001/XMLSchema#string

Shahana Majid

http://www.w3.org/2001/XMLSchema#string

Sharanjot Saini

http://www.w3.org/2001/XMLSchema#string

Soichiro Yamamura

http://www.w3.org/2001/XMLSchema#string

Sumit Arora

http://www.w3.org/2001/XMLSchema#string

Takeshi Chiyomaru

http://www.w3.org/2001/XMLSchema#string

P2860

Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription

A microRNA expression signature of human solid tumors defines cancer gene targets

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer

Epithelial-mesenchymal transitions in tumour progression

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

MicroRNA expression profiles classify human cancers

DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters

P304

73-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-12-2952

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23147995

http://www.w3.org/2001/XMLSchema#string

P932

3910324

http://www.w3.org/2001/XMLSchema#string